Health: pharmaceuticals; administration of epinephrine; modify. Amends secs. 17744a & 17744d of 1978 PA 368 (MCL 333.17744a & 333.17744d). TIE BAR WITH: HB 5054'25, HB 5049'25, HB 5051'25, HB 5052'25, HB 5053'25

Michigan House Bill 5050 aims to modify the administration of epinephrine by allowing prescribers to issue prescriptions for auto-injectable epinephrine delivery systems directly to authorized entities, such as schools or camps, rather than to individual patients. This change is intended to enhance the availability and prompt administration of epinephrine in emergency situations. The bill amends sections 17744a and 17744d of the Public Health Code (1978 PA 368) to facilitate this process. Additionally, the bill is tied to several other bills (HB 5054, HB 5049, HB 5051, HB 5052, and HB 5053), indicating a coordinated legislative effort on related health and safety measures. ([legiscan.com](https://legiscan.com/MI/bill/HB5050/2025?utm_source=openai))

While specific media coverage on Michigan House Bill 5050 is not readily available, the bill's intent to improve access to life-saving epinephrine aligns with public health priorities. By enabling authorized entities to possess epinephrine auto-injectors, the bill could lead to quicker responses during allergic emergencies, potentially saving lives. This proactive approach may be viewed favorably by health professionals and organizations advocating for enhanced emergency preparedness.

Although direct media reactions to Michigan House Bill 5050 are not found, some stakeholders might express concerns about the bill's implementation. Questions could arise regarding the training and readiness of authorized entities to properly administer epinephrine, as well as the potential for misuse or overuse. Additionally, there may be apprehension about the adequacy of oversight and accountability measures to ensure the safe and appropriate use of epinephrine auto-injectors in non-medical settings.